Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer

被引：14

作者：

Dash, Raju ^{[1
]}

Uddin, Mir Muhammad Nasir ^{[2
]}

Hosen, S. M. Zahid ^{[3
]}

Bin Rahim, Zahed ^{[1
]}

Dinar, Abu Mansur ^{[4
]}

Kabir, Mohammad Shah Hafez ^{[5
]}

Sultan, Ramiz Ahmed ^{[2
]}

Islam, Ashekul ^{[6
]}

Hossain, Md Kamrul ^{[2
]}

机构：

[1] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong 4000, Bangladesh

[2] Univ Chittagong, Dept Pharm, Chittagong 4331, Bangladesh

[3] BCSIR, Pharmacol Res Div, MMDDL, Chittagong 4220, Bangladesh

[4] Sq Pharmaceut Ltd, Qual Control Operat, Dhaka, Bangladesh

[5] Int Islamic Univ Chittagong, Dept Pharm, Chittagong 4203, Bangladesh

[6] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong 4331, Bangladesh

来源：

BIOINFORMATION | 2015年 / 11卷 / 12期

关键词：

COX-2; FlexX; ArgusLab; Flavonoids; Cancer;

D O I：

10.6026/97320630011543

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Cydooxygenase-2 (COX-2) catalyzed synthesis of prostaglandin E2 and it associates with tumor growth, infiltration, and metastasis in preclinical experiments. Known inhibitors against COX-2 exhibit toxicity. Therefore, it is of interest to screen natural compounds like flavanoids against COX-2. Molmular docking using 12 known flavanoids against COX-2 by FlexX and of ArgusLab were performed. All compounds showed a favourable binding energy of >-10 KJ/mol in FlexX and > -8 kcal/mol in ArgusLab. However, this data requires in vitro and in vivo verification for further consideration.

引用

页码：543 / 549

页数：7

共 113 条

[11] Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer [J].

Bishayee, Anupam ;

Ahmed, Shamima ;

Brankov, Nikoleta ;

Perloff, Marjorie .

FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 :980-996

[12] Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs [J].

Bohm, HJ .

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1998, 12 (04) :309-323

[13] Luteolin Inhibits Protein Kinase Cε and c-Src Activities and UVB-Induced Skin Cancer [J].

Byun, Sanguine ;

Lee, Ki Won ;

Jung, Sung Keun ;

Lee, Eun Jung ;

Hwang, Mun Kyung ;

Lim, Sung Hwan ;

Bode, Ann M. ;

Lee, Hyong Joo ;

Dong, Zigang .

CANCER RESEARCH, 2010, 70 (06) :2415-2423

[14] Human epidermal growth factor receptor-2-positive breast cancer: current management of early, advanced, and recurrent disease [J].

Callahan, Rena ;

Hurvitz, Sara .

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2011, 23 (01) :37-43

[15] Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy [J].

Cerella, Claudia ;

Sobolewski, Cyril ;

Dicato, Mario ;

Diederich, Marc .

BIOCHEMICAL PHARMACOLOGY, 2010, 80 (12) :1801-1815

[16]

Chan MWY, 2007, ONCOL REP, V18, P1557

[17]

Chen J, 2010, NUTR CANC, V62, P1

[18] Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors [J].

Consalvi, Sara ;

Alfonso, Salvatore ;

Di Capua, Angela ;

Poce, Giovanna ;

Pirolli, Adele ;

Sabatino, Manuela ;

Ragno, Rino ;

Anzini, Maurizio ;

Sartini, Stefania ;

La Motta, Concettina ;

Mannelli, Lorenzo Di Cesare ;

Ghelardini, Carla ;

Biava, Mariangela .

BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (04) :810-820

[19] Molecular docking of fisetin with AD associated AChE, ABAD and BACE1 proteins [J].

Dash, Raju ;

Bin Emran, Talha ;

Uddin, Mir Muhammad Nasir ;

Islam, Ashekul ;

Junaid, Md .

BIOINFORMATION, 2014, 10 (09) :562-568

[20] Inflammation in prostate carcinogenesis [J].

De Marzo, Angelo M. ;

Platz, Elizabeth A. ;

Sutcliffe, Siobhan ;

Xu, Jianfeng ;

Gronberg, Henrik ;

Drake, Charles G. ;

Nakai, Yasutomo ;

Isaacs, William B. ;

Nelson, William G. .

NATURE REVIEWS CANCER, 2007, 7 (04) :256-269

← 1 2 3 4 5 6 7 8 9 10 →